載入...
Outcomes of Neoadjuvant Chemoradiation With and Without Systemic Chemotherapy in Resectable and Borderline Resectable Pancreatic Adenocarcinoma
Introduction: Neoadjuvant therapy is increasingly being used for localized pancreatic adenocarcinoma. While there is evidence supporting neoadjuvant systemic chemotherapy as well as chemoradiation, more evidence is needed to determine whether systemic chemotherapy with chemoradiation offers benefits...
Na minha lista:
| 發表在: | Front Oncol |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7525017/ https://ncbi.nlm.nih.gov/pubmed/33042792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01461 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|